InsiderTrades.com logo

MDP Insider Trading

Insider Ownership Percentage: 9.14%
Insider Buying (Last 12 Months): C$10,916.00
Insider Selling (Last 12 Months): C$0.00

Medexus Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Medexus Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Medexus Pharmaceuticals Share Price & Price History

Current Price: C$2.93
Price Change: ▼ Price Decrease of -0.13 (-4.25%)
As of 07/11/2025 04:59 PM ET

This chart shows the closing price history over time for MDP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Medexus Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/19/2024Kenneth D'entremontDirectorBuy3,000C$2.50C$7,500.00
8/26/2024Brendon BuschmanSenior OfficerBuy1,400C$2.44C$3,416.00
6/28/2024Kenneth D'entremontDirectorBuy5,000C$1.80C$9,000.00
2/13/2024Benoit GravelDirectorBuy3,200C$1.69C$5,408.00
9/21/2022Kenneth D'entremontDirectorBuy10,000C$1.19C$11,900.00592,057
See Full Table

SEC Filings (Institutional Ownership Changes) for Medexus Pharmaceuticals (TSE:MDP)

8.32% of Medexus Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Medexus Pharmaceuticals logo
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action.
Read More on Medexus Pharmaceuticals

Today's Range

Now: C$2.93
Low: C$2.89
High: C$3.12

50 Day Range

MA: C$2.93
Low: C$2.50
High: C$3.40

52 Week Range

Now: C$2.93
Low: C$1.71
High: C$5.56

Volume

24,029 shs

Average Volume

78,828 shs

Market Capitalization

C$65.60 million

P/E Ratio

14.01

Dividend Yield

N/A

Beta

1.96

Who are the company insiders with the largest holdings of Medexus Pharmaceuticals?

Medexus Pharmaceuticals' top insider shareholders include:
  1. Benoit Gravel (Director)
  2. Brendon Buschman (Senior Officer)
  3. Kenneth D'entremont (Director)
Learn More about top insider investors at Medexus Pharmaceuticals.